Evidence map›Paper›PMID 31753042›Full record

ArticleHuman genomics2019

Common polymorphic inversions at 17q21.31 and 8p23.1 associate with cancer prognosis.

Carlos Ruiz-Arenas, Alejandro Cáceres, Victor Moreno, Juan R González

Open access · goldAbstract read
In one paragraph

Article in Human genomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Carlos Ruiz-ArenasBarcelona Institute for Global Health, ISGlobal, Doctor Aiguader 88, 08003, Barcelona, Spain.
Alejandro CáceresBarcelona Institute for Global Health, ISGlobal, Doctor Aiguader 88, 08003, Barcelona, Spain.
Victor MorenoPrograma de Prevención y Control del Cáncer, Instituto Catalán de Oncología, L'Hospitalet, Barcelona, Spain.
Juan R GonzálezBarcelona Institute for Global Health, ISGlobal, Doctor Aiguader 88, 08003, Barcelona, Spain. juanr.gonzalez@isglobal.org.ORCID 0000-0003-3267-2146
Universitat Pompeu Fabra · ESInstitut Català d'Oncologia · ES

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca #016FI_B 00272Ministerio de Economía, Industria y Competitividad, Gobierno de España (ES) MTM2015-68140-R
6 · The paper itself

Abstract

backgroundChromosomal inversions are structural genetic variants where a chromosome segment changes its orientation. While sporadic de novo inversions are known genetic risk factors for cancer susceptibility, it is unknown if common polymorphic inversions are also associated with the prognosis of common tumors, as they have been linked to other complex diseases. We studied the association of two well-characterized human inversions at 17q21.31 and 8p23.1 with the prognosis of lung, liver, breast, colorectal, and stomach cancers.

resultsUsing data from The Cancer Genome Atlas (TCGA), we observed that inv8p23.1 was associated with overall survival in breast cancer and that inv17q21.31 was associated with overall survival in stomach cancer. In the meta-analysis of two independent studies, inv17q21.31 heterozygosity was significantly associated with colorectal disease-free survival. We found that the association was mediated by the de-methylation of cg08283464 and cg03999934, also linked to lower disease-free survival.

conclusionsOur results suggest that chromosomal inversions are important genetic factors of tumor prognosis, likely affecting changes in methylation patterns.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseasePolymorphism, GeneticAdolescentAdultAgedAged, 80 and overChromosome InversionChromosomes, Human, Pair 17Chromosomes, Human, Pair 8CpG IslandsDisease-Free SurvivalDNA MethylationFemaleGene Expression Regulation, NeoplasticHumansCancer prognosisChromosomal inversionsDNA methylationGene expressionGenetic epidemiology

Identifiers

PMID31753042
PMCPMC6873427
OpenAlexW2991433478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.